Dec 29, 2025
51:50
For every 50 shares held, investors received 51. The price per share adjusted from $61900.00 to $60686.27.
The split itself did not change the total investment value.
Celltrion Pharm Inc. (KRX:068760) operates in the Pharmaceuticals: major industry.
Celltrion Pharm Inc. company overviewCelltrion Pharm Inc.'s most recent stock split was on December 29, 2025. It was a 51-for-50 forward split, so shareholders received 51 shares for every 50 they held.
Celltrion Pharm Inc. (KRX:068760) has split its stock 11 times: a 21-for-20 split on December 29, 2014, a 103-for-100 split on December 29, 2015, a 21-for-20 split on December 28, 2016, a 51-for-50 split on December 27, 2017, a 21-for-20 split on December 27, 2019, a 51-for-50 split on December 29, 2020, a 103-for-100 split on December 29, 2021, a 21-for-20 split on December 28, 2022, a 21-for-20 split on December 27, 2023, a 21-for-20 split on December 27, 2024, and a 51-for-50 split on December 29, 2025.
Celltrion Pharm Inc. has split its stock 11 times. This history records 11 forward splits between December 29, 2014 and December 29, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Celltrion Pharm Inc.'s 51-for-50 split on December 29, 2025, every 50 shares became 51 shares.
Celltrion Pharm Inc. has not announced a new split in our records. Its most recent split was on December 29, 2025, less than a year ago. Companies announce splits in advance, and any new KRX:068760 split will appear on this page.
Already premium?